![Ronald Peck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Peck
Keine laufenden Positionen mehr
Profil
Ronald Peck ist Chief Medical Officer von Arvinas, Inc. In der Vergangenheit war Dr. Peck Vice President für die globale Entwicklung von Yervoy bei Bristol Myers Squibb Co., Chief Medical Officer bei Kolltan Pharmaceuticals, Inc. und Senior Vice President für klinische Forschung bei Tesaro, Inc. sowie Assistenzprofessor an der University of Virginia. Dr. Peck erwarb einen Bachelor-Abschluss an der Georgetown University und einen Doktortitel am Sidney Kimmel Medical College.
Ehemalige bekannte Positionen von Ronald Peck
| Unternehmen | Position | Ende |
|---|---|---|
| ARVINAS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 18.03.2024 |
| TESARO INC | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2019 |
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures monoclonal antibody drugs | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.05.2015 |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.02.2000 |
Ausbildung von Ronald Peck
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures monoclonal antibody drugs | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sidney Kimmel Medical College
 Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
